Observational studyThe Lancet. Rheumatology2025

Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.

Anna-Maria Hoffmann-Vold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.